Ecolab reported a 1% increase in sales to $4.0 billion, including a 2% headwind from the sale of the global surgical solutions business and a 1% headwind from currency exchange. Organic sales grew by 4%, driven by volume growth and value pricing. Adjusted diluted EPS increased by 19% to $1.83, and the company increased its full-year adjusted diluted EPS outlook to $6.60 - $6.70.
Reported sales increased by 1% to $4.0 billion, including headwinds from the sale of the global surgical solutions business and currency exchange.
Organic sales grew by 4%, with volume growth strengthening to 2% and value pricing in the targeted 2-3% range.
Reported operating income margin was 26.1%, while organic operating income margin increased by 260 bps to 17.9%.
Adjusted diluted EPS increased by 19% to $1.83, excluding special gains and charges and discrete tax items.
Ecolab anticipates a robust conclusion to the year and expects to drive 12-15% growth in adjusted diluted earnings per share in 2025 and beyond.
Visualization of income flow from segment revenue to net income